Number of the records: 1  

Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines

  1. 1.
    SYSNO0191582
    TitleChemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines
    Author(s) Indrová, Marie (UMG-J) RID
    Bubeník, Jan (UMG-J)
    Mikyšková, Romana (UMG-J) RID
    Mendoza, Luis (UMG-J)
    Šímová, Jana (UMG-J) RID
    Bieblová, Jana (UMG-J)
    Jandlová, Táňa (UMG-J)
    Jinoch, P. (CZ)
    Šmahel, M. (CZ)
    Vonka, V. (CZ)
    Pajtasz-Piasecka, E. (PL)
    Source Title International Journal of Oncology. Roč. 22, č. 3 (2003), s. 691-695. - : Spandidos Publications
    Document TypeČlánek v odborném periodiku
    Grant NC7148 GA MZd - Ministry of Health (MZ)
    GA301/00/0114 GA ČR - Czech Science Foundation (CSF)
    GA301/01/0985 GA ČR - Czech Science Foundation (CSF)
    IAA5052203 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    IAA7052002 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    P04A12314, PL - Poland
    -, CZ - Czech Republic
    CEZAV0Z5052915 - UMG-J
    Languageeng
    CountryGR
    Keywords chemotherapy-induced residual tumour disease * immunotherapy * HPV16-associated tumours
    Permanent Linkhttp://hdl.handle.net/11104/0087324
     

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.